НовостиBenzingaNeedham Maintains Buy on Evommune, Lowers Price Target to $25 Needham Maintains Buy on Evommune, Lowers Price Target to $25 Benzinga 2026.11.13 18:19 (GMT+0) Открыть на Benzinga Другие новости